Singh Vanila

USNatural personDirector

Insider

Singh Vanila

USNatural personDirector

Transactions

Issuers

Buys / Sells

0/0

Last tx

29 Jan 2024

Current positions

Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.

Issuer	Shares	Source	Last tx	Detail
Virpax Pharmaceuticals, Inc.	25,000	reported	29 Jan 2024	tx 4+60,274
BIODELIVERY SCIENCES INTERNATIONAL INC	0	reported	22 Mar 2022	tx 25+399,489−303,489

Recent transactions

Date	Type	Issuer	Qty	Price	Signals
29 Jan 2024	GRANT_AWARD	Virpax Pharmaceuticals, Inc.	25,000	0.00 USD	deriv
01 Jan 2023	GRANT_AWARD	Virpax Pharmaceuticals, Inc.	15,000	0.00 USD	deriv
22 Mar 2022	OTHER	BIODELIVERY SCIENCES INTERNATIONAL INC	35,851	0.00 USD
22 Mar 2022	OTHER	BIODELIVERY SCIENCES INTERNATIONAL INC	81,008

InsiderLens aggregates public information issued by financial regulators (SEC, AMF, FCA, BaFin, AFM, FI, HKEX, ASX). The service constitutes neither investment advice nor a recommendation to buy or sell. Past performance is no guarantee of future results. Investing in financial instruments carries the risk of capital loss.

Current positions

Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.

Issuer	Shares	Source	Last tx	Detail
Virpax Pharmaceuticals, Inc.	25,000	reported	29 Jan 2024	tx 4+60,274
BIODELIVERY SCIENCES INTERNATIONAL INC	0	reported	22 Mar 2022	tx 25+399,489−303,489

Recent transactions

Date	Type	Issuer	Qty	Price	Signals
29 Jan 2024	GRANT_AWARD	Virpax Pharmaceuticals, Inc.	25,000	0.00 USD	deriv
01 Jan 2023	GRANT_AWARD	Virpax Pharmaceuticals, Inc.	15,000	0.00 USD	deriv
22 Mar 2022	OTHER	BIODELIVERY SCIENCES INTERNATIONAL INC	35,851	0.00 USD
22 Mar 2022	OTHER	BIODELIVERY SCIENCES INTERNATIONAL INC	81,008